1
|
Bartz D and Goldberg A: Medication
abortion. Clin Obstet Gynecol. 52:140–150. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Doraiswami S, Johnson T, Rao S, Rajkumar
A, Vijayaraghavan J and Panicker VK: Study of endometrial pathology
in abnormal uterine bleeding. J Obstet Gynaecol India. 61:426–430.
2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Spitz IM: Mifepristone: where do we come
from and where are we going? Clinical development over a quarter of
a century. Contraception. 82:442–452. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Chuang CH, Chang PJ, Hsieh WS, Tsai YJ,
Lin SJ and Chen PC: Chinese herbal medicine use in Taiwan during
pregnancy and the postpartum period: a population-based cohort
study. Int J Nurs Stud. 46:787–795. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Liao HL, Ma TC, Chiu YL, Chen JT and Chang
YS: Factors influencing the purchasing behavior of TCM outpatients
in Taiwan. J Altern Complement Med. 14:741–748. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Chang PJ, Tseng YC, Chuang CH, et al: Use
of Sheng-Hua-Tang and health-related quality of life in postpartum
women: a population-based cohort study in Taiwan. Int J Nurs Stud.
47:13–19. 2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ho M, Li TC and Su SY: The association
between traditional Chinese dietary and herbal therapies and
uterine involution in postpartum women. Evid Based Complement
Alternat Med. 2011:9182912011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Geng F, Wang F, Zou T, et al: Rapid
identification of the multiple absorbed bioactive components and
metabolites in rat serum after oral administration of Wu-Jia
Sheng-Hua capsule by UPLC-ESI-MS. J Anal Methods Chem.
2013:3189612013. View Article : Google Scholar : PubMed/NCBI
|
9
|
IRAC (Interagency Research Animal
Committee), . U.S. Government Principles for the Utilization and
Care of Vertebrate Animals Used in Testing, Research and
TrainingFederal Register. Office of Technology Policy; Washington:
pp. 116–118. 1985
|
10
|
Li X, Yuan FL, Zhao YQ, Lu WG, Li CW and
He CH: Effect of leonurine hydrochloride on endothelin and the
endothelin receptor-mediated signal pathway in medically-induced
incomplete abortion in rats. Eur J Obstet Gynecol Reprod Biol.
169:299–303. 2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Cheng L: Medical abortion in early
pregnancy: experience in China. Contraception. 74:61–65. 2006.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Li L, Zhou Z and Huang L: Abnormal
expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated
with prolonged uterine bleeding after a medical abortion with
mifepristone and misoprostol. Acta Obstet Gynecol Scand.
88:673–679. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Li X, Yuan FL, Zhao YQ, et al: Effects of
leonurine hydrochloride on medically induced incomplete abortion in
early pregnancy rats. Eur J Obstet Gynecol Reprod Biol.
159:375–380. 2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Livingstone M and Fraser IS: Mechanisms of
abnormal uterine bleeding. Hum Reprod Update. 8:60–67. 2002.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Lockwood CJ: Mechanisms of normal and
abnormal endometrial bleeding. Menopause. 18:408–411. 2011.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Smith SK: Regulation of angiogenesis in
the endometrium. Trends Endocrinol Metab. 12:147–151. 2001.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Vadlamudi RK, Balasenthil S, Broaddus RR,
Gustafsson JA and Kumar R: Deregulation of estrogen receptor
coactivator proline-, glutamic acid- and leucine-rich
protein-1/modulator of nongenomic activity of estrogen receptor in
human endometrial tumors. J Clin Endocrinol Metab. 89:6130–6138.
2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Im A and Appleman LJ: Mifepristone:
pharmacology and clinical impact in reproductive medicine,
endocrinology and oncology. Expert Opin Pharmacother. 11:481–488.
2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Chwalisz K, Perez MC, Demanno D, Winkel C,
Schubert G and Elger W: Selective progesterone receptor modulator
development and use in the treatment of leiomyomata and
endometriosis. Endocr Rev. 26:423–438. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Clark TJ: Modern management of abnormal
uterine bleeding. Obstetrician and Gynaecologist. 11:792009.
View Article : Google Scholar
|
21
|
Fraser IS, Hickey M and Song JY: A
comparison of mechanisms underlying disturbances of bleeding caused
by spontaneous dysfunctional uterine bleeding or hormonal
contraception. Hum Reprod. 11 (Suppl 2):165–178. 1996. View Article : Google Scholar : PubMed/NCBI
|
22
|
Williams AR, Critchley HO, Osei J, et al:
The effects of the selective progesterone receptor modulator
asoprisnil on the morphology of uterine tissues after 3 months
treatment in patients with symptomatic uterine leiomyomata. Hum
Reprod. 22:1696–1704. 2007. View Article : Google Scholar : PubMed/NCBI
|
23
|
Evans J, Kaitu'u-Lino T and Salamonsen LA:
Extracellular matrix dynamics in scar-free endometrial repair:
perspectives from mouse in vivo and human in vitro studies. Biol
Reprod. 85:511–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Frantz C, Stewart KM and Weaver VM: The
extracellular matrix at a glance. J Cell Sci. 123:4195–4200. 2010.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Hickey M and Fraser IS: The structure of
endometrial microvessels. Hum Reprod. 15 (Suppl 3):57–66. 2000.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Lipowsky HH: Microvascular rheology and
hemodynamics. Microcirculation. 12:5–15. 2005. View Article : Google Scholar : PubMed/NCBI
|